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Since 1991, after the publication of the North
American Symptomatic Carotid Endarterectomy
(NASCET) and European Carotid Surgery (ECST)
trials,1,2 the treatment of patients with severe symp-
tomatic internal carotid artery (ICA) stenosis is no
longer a matter of discussion. The results of two
large multicenter trials indicated that male patients
with an asymptomatic ICA stenosis greater than 60%
will benefit from carotid endarterectomy (CEA),
provided that the patients have a good life expectan-
cy and surgery is performed with a less than 3% peri-
operative morbidity and mortality rate.3,4
The treatment of patients with ICA occlusion rep-
resents an even more complex and debatable problem.
In general, ICA occlusion represents a dangerous
condition, which exposes patients to a high risk for
cerebrovascular events.5-8 It has been shown that
when ICA stenosis progresses to occlusion, patients
have a risk of ipsilateral stroke that is as high as 25%.5
However, it is mainly the onset of ICA occlusion
that appears to correlate with a dangerous and
potentially fatal outcome4,5,7; once the occlusion has
been established, the subsequent risk of cerebrovas-
cular events seems to be lower.6,9
The prognosis of ICA occlusion could differ
according to its clinical presentation. Indeed, the inci-
dence of ipsilateral strokes may be as high as 27% per
year in patients with symptomatic occlusions6,8; it has
been reported to range from 0% to 5% per year in its
asymptomatic presentation.9,10 Finally, it is currently
uncertain whether, and to what extent, the contempo-
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rary presence of atherosclerotic narrowing of the con-
tralateral ICA, or, generally, of the epiaortic branches,
may complicate the outcome of patients with ICA
occlusion.
Thus, after a definite diagnosis of ICA occlusion
has been established, it is difficult to quantify its asso-
ciated risk of subsequent cerebrovascular events. Such
an issue is particularly relevant for the optimal man-
agement of this condition.
The aim of this study was to prospectively follow
up patients with an ICA occlusion to clarify its 
clinical implications. We sought to verify whether 
different clinical presentations and the presence of
atherosclerotic lesions in the carotid system con-
tralateral to the occlusion could affect the clinical
outcome of these patients.
METHODS
All consecutive patients referred to the Unit Care
of Angiology of the University Hospital of Padua for
a screening of the carotid and vertebral arteries were
eligible for the study. Reasons for screening were the
presence of risk factors for atherosclerosis (smoking,
hypercholesterolemia, hypertension, and diabetes
mellitus), neck bruits, or either aspecific (syncope,
vertigo, dizziness) or specific symptoms (transient
ischemic attack, reversible ischemic neurologic
deficit, or stroke of the carotid territory).
All patients who were included in the study
underwent a complete clinical examination, includ-
ing a predefined interview, a physical examination
(including a neurological evaluation by an experi-
enced consultant neurologist), an electrocardiogram,
and blood testing. The objective demonstration of an
ICA occlusion was the only inclusion criterion.
The noninvasive objective diagnosis of an ICA
occlusion was accomplished by means of a combined
approach based on an echo-color Doppler (ECD)
assessment of the carotid arteries (5.0- and 7.5-
MHz linear probes) and a continuous-wave Doppler
(CWD) evaluation of the periorbital flow (8-MHz
probe). The ECD criteria for ICA occlusion were a
lack of color-flow imaging of ICA in the absence of
extensive plaque calcification, the detection of a
diastolic flow toward zero in the common carotid
artery (CCA), the presence of longitudinal pulsing
of the ICA walls, and a clear demonstration of an
external carotid artery (ECA) and its collaterals (eg,
the visualization of the superior thyroid artery). The
only CWD criterion was the detection of a reduced
or inverted periorbital flow ipsilateral to the suspect-
ed ICA occlusion. The diagnosis of ICA occlusion
was established once all five criteria were fulfilled;
otherwise, arteriography was required as a means of
confirming the suspected ICA occlusion.
Once a definite diagnosis of ICA occlusion had
been established, the degree of stenosis, if any, of the
ipsilateral CCA and external carotid ECA and of the
contralateral CCA and ICA was recorded for further
follow-up evaluations, with information concerning
the presence/absence and the direction of flow in the
vertebral arteries. According to published crite-
ria,11,12 the degree of atherosclerotic narrowing was
classified as mild (less than 50%), moderate (50%-
74%), severe (75%-99%), and occlusion. Patients with
severe (more than 75%) stenosis of the contralateral
ICA were scheduled for carotid endarterectomy
(CEA).
All included patients were entered into a long-
term prospective follow-up protocol. At each visit,
they had to undergo a complete vascular examina-
tion plus noninvasive ECD and CWD evaluation of
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Fig 1. Cumulative proportion of stroke-free patients, ana-
lyzed separately for symptomatic (number of events = 2),
and asymptomatic (number of events = 1) patients.
Fig 2. Cumulative proportion of patients surviving, ana-
lyzed separately for symptomatic (number of events = 5),
and asymptomatic (number of events = 4) patients.
the carotid, vertebral, and periorbital district.
Patients were seen 3, 6, and 12 months after inclu-
sion and then every 6 months, or earlier if any sign
or symptom possibly related to a neurological event
appeared. Patients were instructed to immediately
come to our center if any of the symptoms or signs
of a neurological event, which were listed in a spe-
cific log to be used at home, appeared.
The primary end points of the study were death
(overall and stroke-related) and nonfatal cerebrovas-
cular events (overall and ipsilateral). Secondary end
points were the onset or significant progression of
atherosclerotic disease in the CCA and ICA opposite
to the occlusion and in the CCA and ECA on the
side of the occlusion, as expressed by means of ECD
percent-stenosis measurements. A “significant” pro-
gression of atherosclerotic disease was defined as a
shift to a higher stenosis class.
Descriptive statistics were calculated with stan-
dard methods. Differences in overall and stroke-
related mortality rates between asymptomatic and
symptomatic patients were estimated by means of
the Kaplan-Meier product-limit method.
RESULTS
Between January 1990 and December 1991, 1433
patients were referred to our center for a noninvasive
evaluation of the epiaortic arteries. Among these, 41
patients with ICA occlusion were identified. The mean
age (plus or minus SD) at the time of referral was 65.2
± 8.4 years; 33 patients (80%) were men. The patient
characteristics and their outcome at the end of the fol-
low-up period are listed in Tables I and II.
Nineteen patients were symptomatic at the time
of presentation, and their symptoms were related to
the same cerebral side of ICA occlusion. Fourteen of
these patients underwent a computed tomography
scan of the brain, and 13 patients had evidence of
brain infarction in the hemisphere omolateral to the
occluded ICA. The other 22 patients were com-
pletely asymptomatic or had aspecific manifestations
(vertigo, dizziness, or fainting).
The diagnosis of an occluded ICA was established
by means of noninvasive methods in 35 patients
(85%), and a confirmatory arteriogram was required 
in six patients. The confirmatory arteriogram was
required because extended calcified plaques could have
made the diagnosis of ICA occlusion falsely positive.
None of the diagnoses were made by means of the
analysis of the flow in the supraorbital arteries. The
results of supraorbital Doppler scanning were abnor-
mal in all patients; 28 patients had inverted flow, and
13 patients had a normal direction of flow but reduc-
tion in the velocity. All patients were receiving
antiplatelet therapy, either aspirin (100-325 mg/d) or
ticlopidine (250 mg twice a day).
All patients had different degrees of atherosclerotic
lesions in the territory of the contralateral ICA; seven
patients (17.1%) had a moderate ICA stenosis (50%-
74%), five patients (12.2%) had a severe ICA stenosis
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Table I. Clinical profile and outcome of patients with symptomatic internal carotid artery occlusion
First visit Follow-up
Degree of Duration Events Stenosis Death 
Age (y) Sex Symptoms stenosis (%)* (mo) (neurologic) progress* CEA* (cause)
83 M Amaurosis 20 to 49 44 N N N –
66 M TIA 20 to 49 60 N N N –
49 M Stroke 20 to 49 57 N N N –
64 F TIA 20 to 49 50 N N N –
57 M TIA 50 to 74 49 N N Y –
62 M TIA 20 to 49 51 N N N –
70 M TIA 20 to 49 44 N N N –
68 F Minor stroke 50 to 74 55 N N N –
77 M TIA Occlusion 2.5 N N N HF
68 F TIA 50 to 74 29 N N N C
75 M Stroke 50 to 74 38 N N N C
67 M Stroke 20 to 49 59 N N N –
72 M Stroke 20 to 49 62 N N N –
55 M Stroke 20 to 49 52 N N N –
56 M TIA 75 to 99 48 N N Y –
63 M Amaurosis 0 to 19 59 N N N –
41 M TIA Occlusion 60 N N N –
68 M Stroke 75 to 99 2 days – – – Stroke
56 M Stroke 20 to 49 2 days – – – Stroke
*Atherosclerotic lesions of the contralateral (ie, opposite to occluded side) internal carotid artery.
CEA, Carotid endarterectomy; TIA, transient ischemic attack; M, male; F, female; N, none; Y, yes; HF, heart failure; C, cancer.
(75%-99%), and four patients (9.7%) had a bilateral
ICA occlusion. The other 25 patients had a less than
50% ICA stenosis (five patients had a less than 20%
stenosis; 20 patients had a stenosis between 20% and
49%). Twenty patients also had atherosclerotic lesions
of the CCA and ECA on the same side of occlusion; of
these, 11 patients had a mild stenosis of the ECA, five
patients had a moderate stenosis of the ECA, and one
patient had a severe stenosis of the ECA.
All patients, except one asymptomatic patient
who spontaneously withdrew from the study after
12 months, were followed up for a mean (plus or
minus SD) of 44.5 ± 18.4 months between 1991
and 1996. The patient who withdrew was complete-
ly asymptomatic and in good clinical condition, until
he spontaneously withdrew from follow-up.
Nine patients died during the follow-up period
(four of the patients belonged to the asymptomatic
cohort) of stroke (three patients), cancer (three
patients), rupture of an abdominal aortic aneurysm
(one patient), myocardial infarction (one patient),
and acute cardiovascular failure (one patient). Of the
three patients who died of stroke, two died after 2
days of inclusion, whereas the third patient died after
24 months of follow-up. Therefore, among study
patients, the overall mortality rate was 22.0% (95%
CI, 10.6-37.6) or 5.9% per year, and the stroke-
related mortality and ipsilateral stroke rate was 7.3%
(95% CI, 1.5-19.9) or 2% per year.
None of the patients experienced nonfatal cere-
brovascular events during the follow-up period. No
significant differences in overall and stroke-related
mortality were observed between asymptomatic and
symptomatic patients (Figs 1 and 2). By the end of the
follow-up period, the cumulative proportion of stroke-
free survival (Fig 1) was 89.2% (SE, 21.9; 95% CI,
46.3-100) for the symptomatic patients and 94.7%
(SE, 22.4; 95% CI, 50.8-100) for the asymptomatic
patients (P = .47 by means of the log-rank test). The
relative figures for survival (Fig 2) were 73.7% (SE,
19.7; 95% CI, 35.1-100) for the symptomatic group
and 81.1% (SE, 27.7; 95% CI, 26.8-100) for the
asymptomatic group (P = .52 by means of the log-rank
test). Five patients were found to have a severe (more
than 75%) stenosis of the contralateral ICA. Of these
patients, three underwent CEA according to the pro-
tocol, and no patients experienced cerebrovascular
events during the follow-up period. Of the other two
patients, one died of a stroke 2 days after the initial
diagnosis, whereas the second, a 70-year-old woman,
refused CEA and died 24 months later after repeated
episodes of syncope. An autopsy could not be per-
formed in this patient, and her death was regarded as
stroke related.
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Table II.  Clinical profile and outcome of patients with asymptomatic internal carotid artery occlusion
First visit Follow-up
Degree of Duration Events Stenosis Death 
Age (y) Sex stenosis* (%) (mo) (neurologic) progress* CEA* (cause)
69 M 20 to 49 53 N N N –
68 F 20 to 49 57 N N N –
62 M 0 to 19 51 N N N –
68 F 75 to 99 49 N N Y –
71 M 0 to 19 54 N N N –
55 M 20 to 49 50 N N N –
69 M 20 to 49 60 N N N –
68 M Occlusion 64 N N N –
70 M 20 to 49 – N N N –
69 M 20 to 49 42 N N N AMI
76 M 0 to 19 11 N N N C
70 F 75 to 99 24 N N N Stroke
75 M 50 to 74 7 N N N AAAR
62 M 50 to 74 50 N N Y –
48 M 20 to 49 56 N N N –
70 M Occlusion 51 N N N –
75 M 50 to 74 51 N N N –
65 M 20 to 49 47 N N N –
65 F 0 to 19 54 N N N –
61 M 20 to 49 43 N N N –
59 F 75 to 99 56 N N Y –
63 M 20 to 49 65 N N N –
*Atherosclerotic lesions of the contralateral (ie, opposite to occluded side) internal carotid artery.
CEA, Carotid endarterectomy; TIA, transient ischemic attack; M, male; F, female; N, none; Y, yes; HF, heart failure; AMI, acute myocar-
dial infarction; C, cancer; AAAR, abdominal aortic aneurysm rupture.
Seven patients had a moderate contralateral ICA
stenosis; of these, two patients were scheduled for
CEA by their attending physicians, whereas the other
five patients did not undergo surgical procedures.
None of the patients experienced cerebrovascular
events during the follow-up period, but three of the
five patients in whom CEA was not performed died,
of aortic aneurysm rupture (one patient), of lung car-
cinoma (one patient), and of gastric carcinoma (one
patient), after 7, 38, and 29 months, respectively.
Four patients had a bilateral ICA occlusion. Of
these, three patients had a completely uneventful
follow-up period, and one patient died of heart fail-
ure 2.5 months after inclusion.
Throughout the study period, none of the
patients experienced significant progression of the
atherosclerotic lesions in the contralateral ICA and
CCA or in the CCA and ECA on the same side of the
occlusion. Conversely, a partial spontaneous recanal-
ization of the occluded ICA was observed in only one
patient, approximately 48 months after inclusion.
DISCUSSION
The incidence of ipsilateral stroke in patients
with a severe symptomatic ICA stenosis is high,
approaching 9% after 2 years of follow-up in patients
who undergo CEA and 26% in patients who are
treated pharmacologically.1,2 Asymptomatic ICA
stenosis seems to have a better prognosis, with an
incidence of ipsilateral stroke approximately 2% per
year.3,4 The optimal treatment of these patients,
with some limitations for patients with asympto-
matic disease, is currently represented by CEA plus
long-term antiplatelet therapy.1-4
In ICA occlusion, mainly the time of onset seems
to correlate with the development of stroke. In the
study by Nicholls et al,5 in which carotid stenosis was
prospectively followed to occlusion, 25% of the patients
experienced a stroke after occlusion. In another study
by Bornstein and Norris,9 two groups of asymptomatic
patients were enrolled: one of patients with tight ICA
stenosis progressing to occlusion during the study peri-
od and another of patients with already occluded ICAs
at the time of referral. Three of the 21 patients belong-
ing to the first group experienced ipsilateral strokes
during the follow-up period (3.8% per year), as com-
pared with none of the 19 patients in the second group.
Conversely, when ICA occlusion is already established,
it seems to represent a slightly less dangerous condi-
tion, because the corresponding incidences of ipsilater-
al stroke are reported to be around 5% per year in
patients with symptomatic occlusions and as high as 4%
per year in patients without neurological symptoms.6-10
To our knowledge, this is the first study enrolling
both symptomatic and asymptomatic consecutive
patients with ICA occlusion in a long-term prospec-
tive follow-up. Three of our patients, during a mean
follow-up period of 45 months, experienced a symp-
tomatic (fatal) cerebrovascular event. Two patients
were in the symptomatic group and died of an
extension of their presenting stroke after 2 days; one
patient was in the asymptomatic group and died 24
months after enrollment after repeated syncope
episodes. Because we could not perform an autopsy
on this third patient, we cannot be sure that she died
of a stroke. However, we considered this event to be
an end point, as is usually done in management stud-
ies, thus making the prognosis of asymptomatic ICA
occlusion even more benign.
Our study has several potential limitations. First,
because of the small sample size, our study may have
had insufficient power to detect differences in progno-
sis between symptomatic and asymptomatic patients.
Second, serial (at baseline and at the end of follow-up)
computed tomography scanning was not performed
routinely, and thus some asymptomatic cerebrovascu-
lar events might have been missed. Finally, because
most of the patients included in the symptomatic
group were inpatients, we cannot exclude a referral
bias (either in favor of or against severely diseased
patients), although this is very unlikely.
We believe our results are valid, because patients
were identified by means of ECD, a method that
warrants a 100% accuracy level in the detection of
ICA occlusion,13 or, in cases of indeterminate
results, by means of angiography, which is the gold
standard for the diagnosis of cerebrovascular dis-
eases.14 Selection bias was avoided by enrolling all
consecutive patients with a diagnosis of ICA occlu-
sion who were referred to our institution during the
study period. Moreover, all patients were closely fol-
lowed up in a prospective way, and only one patient
was lost to follow-up, after 1 year.
Our data are consistent with the data reported by
Bornstein and Norris,9 who reported a 0% mortality
rate in a population of asymptomatic patients. ICA
occlusion seems to be, from the results of our study,
a relatively benign condition in symptomatic
patients also, if you do not consider patients who
died of complications of their presenting stroke.
Two prospective studies of symptomatic patients
with ICA occlusion have been performed to date;6,8
both reported a higher frequency of stroke during
the follow-up period than that observed in our
study. We believe such a discrepancy could be
explained by different selection criteria, because
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when these two studies were performed data from
the NASCET and ECST had not become available,
duplex and ECD had not yet come into use, and
only high-risk (symptomatic) patients were selected
for angiography.
Four of our patients were found to have a bilat-
eral ICA occlusion at entry. Two of these patients
were completely asymptomatic, and the other two
patients had recently experienced a stroke. Three of
these patients were alive and well after more than 5
years of follow-up, and one patient died after 2.5
months of heart failure after a lower-limb amputa-
tion. None of these patients sustained either mild or
severe cerebrovascular events.
The cause of this finding, which should be regard-
ed as an indirect confirmation of the benign outcome
of ICA occlusion, might also be the correction of risk
factors and best medical treatment. In fact, all our
patients were receiving antiplatelet therapy, and 30 of
31 patients quit smoking during the study period.
Until now, no accepted guidelines for the surgi-
cal correction of ICA stenosis contralateral to ICA
occlusion were available, and local policies vary
widely, with generally more aggressive treatment
(eg, surgery performed in patients with a more than
50% ICA stenosis) being performed than in patients
without contralateral occlusion, at least in many vas-
cular centers in Italy.
Our study has also shown that the prognosis for
a patient with ICA occlusion is not worse than that
for a patient with asymptomatic ICA stenosis, so we
recommend CEA only for more than 75% ICA
stenoses, because the performance of CEA in
patients with contralateral ICA occlusion carries a
slight increase in the rate of postoperative stroke and
death.15 Moderate ICA stenosis (50% to 74%) con-
tralateral to ICA occlusion still represents a “gray”
area, in which both CEA or medical treatment alone
are feasible. Properly randomized controlled trials
are needed to resolve this issue.
Finally, we were able to observe one case of spon-
taneous partial recanalization, which occurred after 3
years of follow-up, that was first detected by means of
ECD and confirmed by means of angiography. Two
years later, the partially recanalized ICA was still
patent, and the patient was totally asymptomatic.
In conclusion, ICA occlusion is more frequent
than expected on the basis of previous observations,
and it seems to be a relatively benign condition, in
both its symptomatic and asymptomatic presenta-
tion. Patients with atherosclerotic lesions of the con-
tralateral ICA might be better treated according to
their relative degree of stenosis, irrespective of the
presence of ICA occlusion, and we suggest that CEA
be considered for severe stenoses. Follow-up assess-
ments with ECD are recommended at least once a
year, mainly as a means of monitoring contralateral
ICA stenosis. The spontaneous partial recanalization
of an occluded ICA seems to be a rare event.
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